Montana's Right-to-Try Bill: A Medical Tourism Gamble?
Montana's controversial new law allows access to unapproved experimental drugs, sparking debate. While proponents claim it promotes equitable access, experts question its safety and feasibility. US courts have previously rejected the right of patients to access unapproved experimental treatments. The bill mandates that experimental treatment centers allocate a percentage of profits to support local residents' access, but this might introduce further risk as doctors lack efficacy guarantees. Additionally, the law limits sales to drugs manufactured within Montana, contradicting federal requirements for FDA approval of interstate drug commerce. Despite these hurdles, several clinics have expressed interest, potentially creating a unique medical tourism market.